Kanvas Biosciences: $48 Million Series A Raised For Microbiome Cancer Therapeutics Platform
By Amit Chowdhry ● May 7, 2026
Kanvas Biosciences announced it raised a $48 million Series A financing round to advance microbiome therapeutics designed to improve immunotherapy outcomes for cancer patients. The financing was co-led by existing investors DCVC and Lions Capital LLC, with participation from Gates Foundation, ATHOS KG, Germin8, Ki Tua Fund, Pangaea Ventures, and additional investors.